SCHEMBL8991924

SCHEMBL8991924

C/C(=C1\SCN(C)C1=O)c1cc(C(C)(C)C)c(O)c(C(C)(C)C)c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
NPSR1 Q6W5P4 1/20 0.40
ALDH1A1 P00352 5/20 0.39
HPGD P15428 1/20 0.39
ALOX15 P16050 1/20 0.39
ALOX12 P18054 1/20 0.39
HSD17B10 Q99714 1/20 0.39
APOBEC3G Q9HC16 1/20 0.39
GAA P10253 3/20 0.39
ALOX5 P09917 2/20 0.38
PTGS1 P23219 2/20 0.38
PTGS2 P35354 2/20 0.38
LMNA P02545 1/20 0.36
RECQL P46063 1/20 0.36
CA2 P00918 2/20 0.36
CA1 P00915 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
CYP1A2 P05177 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8895686 1.00 MEN1 (0.40) MEN1KMT2ASMN1; SMN2NPSR1ALDH1A1
SCHEMBL8933377 0.83 SMN1; SMN2 (0.37) MEN1KMT2ASMN1; SMN2NPSR1ALDH1A1
SCHEMBL8933375 0.83 SMN1; SMN2 (0.37) MEN1KMT2ASMN1; SMN2NPSR1ALDH1A1
SCHEMBL8991936 0.73 PTGS2 (0.41) SMN1; SMN2NPSR1ALDH1A1GAAALOX5
SCHEMBL8991938 0.73 PTGS2 (0.41) SMN1; SMN2NPSR1ALDH1A1GAAALOX5
SCHEMBL8532780 0.72 PTGS2 (0.56) MEN1KMT2AALDH1A1GAAALOX5
SCHEMBL8532777 0.72 PTGS2 (0.56) MEN1KMT2AALDH1A1GAAALOX5
SCHEMBL7804613 0.70 MEN1 (0.44) MEN1KMT2AALDH1A1HPGDALOX15
SCHEMBL7804611 0.70 MEN1 (0.44) MEN1KMT2AALDH1A1HPGDALOX15
SCHEMBL8895700 0.69 ALDH1A1 (0.42) MEN1KMT2ANPSR1ALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0722729-A2 Aryl-substituted rhodanines for treating multiple sclerosis ELI LILLY AND COMPANY (US) 1996-07-24 EP disclosed
EP-0391644-B1 Aryl-substituted rhodanine derivatives LILLY CO ELI (US) 1996-06-19 EP disclosed
US-5356917-A Antiischemic, antiinflammatory, antiarthritic agents, treat-ment of dystrophic mammals ELI LILLY AND COMPANY (US) 1994-10-18 US disclosed
US-5158966-A Aryl-substituted rhodanine derivatives THE UNIVERSITY OF COLORADO FOUNDATION, INC. (US) 1992-10-27 US disclosed
EP-0500337-A1 Composition containing aryl-substituted rhodanine derivatives for the treatment of type I diabetes UNIVERSITY OF COLORADO FOUNDATION, INC. (US) 1992-08-26 EP disclosed